Preliminary Program – Detailed
Welcome Words
Nimrod Elmish CEO Cann10, Israel
Yossi Bornstein, CEO Shizim, Chairman Cann10, Israel
CANNABIS, PSYCHOLOGY AND EMOTIONS - THE INFLUENCE OF DIFFERENT CANNABIS COMPOUND ON OUR BODY AND MIND
Raphael Mechoulam, Prof, Institute for Drug Research, The Hebrew University of Jerusalem, Israel
Chair: Shaul Lev Ran, Director of Addiction Medicine and Dual Disorders Clinic, Lev Hasharon Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
Is Cannabis a Cure for the Opioid Epidemic?
David Casarett, Prof. Chief of Palliative Care, Duke University, USA
The Exit Drug: Medical Cannabis Patterns of Use and Substitution for Opioids and Other Substances
Philippe Lucas, VP of Patient Research and Access, Tilray, Canada
.
Innovations in Science and Medicine
12:20-13:30
PANEL DISCUSSION: CANNABIS TREATMENT AS AN EXIT STRATEGY – TO SUBSTITUTE FOR OPIOIDS, ALCOHOL AND OTHER DRUGS
Moderator: Shaul Lev Ran, Prof. Director of Addiction Medicine and Dual Disorders Clinic, Lev Hasharon Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
Elyad Davidson, Prof. Director, Pain Relief Unit at Hadassah Hebrew University Medical Center, Israel
Rami Yaka, Prof, Dr. Leon Deutsch and Dr. Mina Deutsch Chair in Psychopharmacology Head, Program for Advance Studies School of Pharmacy, The Institute for Drug Research (IDR) Faculty of Medicine, The Hebrew University of Jerusalem, Israel
David Casssarett, Prof. Chief of Palliative Care, Professor of Medicine, Duke University/Duke Health, USA
New Technologies, New Opportunities
12:20- 13:30
THE ISRAEL MODEL: A SMALL COUNTRY, A LEADING INDUSTRY
Chair: Kobi Caspi, Co-founder and CFO Cann10, Israel
Nimrod Elmish, CEO, Cann10, Israel
Why is Israel the Right Place to Invest in Medical Cannabis and how does the Israeli Government Promote the Industry?
Ziva Eger, Cheif Executive of Foregin Investments & Industrial Cooperation
The Globalization of Medicalization
Amir Goldstein, Cheif Operations Officer, IMC, Israel
TBA
Industry & Agriculture
12:20-13:30
CANNABIS GENETICS – NEW DEVELOPMENTS
Chair: Gilad Livni, Genetic Development Consultant, Seach Ltd, Israel
The Secrets of the Cannabis Genetics
Jonathan Page, Prof. Cheif Sceintist, Aurora, Canada
Activation of Epigenetics Pass Way for Improving Traits in Different Cultivars
Avner Shenfeld, Prof. Epigenetics Ltd., Israel
Shay Sarid, Co-Founder & CTO, Seach Medical Cannbis Group, Israel
Precise Geonomics for Medical Cannabis
Arnon Heyman, CEO, Canonic Ltd, Israel
PARALLEL SESSIONS
.
Innovations in Science and Medicine
14:30 – 15:00
THE IMPACT OF CANNABIS BASED TREATMENT ON VARIOUS DISEASES-PRE CLINICAL AND CLINICAL RESULTS
Chair: Reuven Or, Prof MD Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Israel
Dysregulation of the Endocannabinoid System in Human Physiology
Yossi Tam, Dr. Head, Obesity and Metabolism Laboratory, The Institute for Drug Research, Faculty of Medicine, Director, Multidisciplinary Center on Cannabinoid Research, The Hebrew University of Jerusalem, Israel
Q&A
15:00 – 16:00
PRE-CLINICAL AND CLINICAL RESULTS
Neurological: The Impact Of Cannabis On Parkinson Related Symptoms
Ruth Djaldetti,Prof. ,Movement Disorder Clinic, Department of Neurology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Israel
The Effect of Cannabis vs. Placebo on Dementia Patients
Vered Hermush, Dr, Medical Director, Geriatric Wing Company NameLaniado Hospital, Israel
Pain Receptors: The Ionotropic Cannabinoids Receptors
Avi Priel, Dr ., Head, Lab of Molecular Pharmacology of Somatosensation and Pain, Israel
The Highs and Lows of Cannabis Treatment in Cancer Patients
Reuven Or, M.D. Bone Marrow Transplantation, Cancer Immunotherapy & Immunobiology, Israel
New Technologies, New Opportunities
14:30-16:00DIGITAL HEALTH AND CANNABIS - IS THE FUTURE HERE? BIG DATA, PREDICTION, AND ARTIFICIAL INTELLIGENCECannformatics: A Bioinformatics and Big Data Approach to Personalized Medical Cannabis.Itzhak Kurek, PhD, CEO & Co-Founder, Cannformatics Inc., IsraelCannabis Big Data - Tracking Patient Outcomes for Predictive AnalyticsDavid Berg, President and CTO, Strainprint Technologies Ltd, CanadaJason Dyck, Canada Research Chair in Molecualr Medicine, University of Alberta, Board of Directors, Aurora Cannabis Inc, CanadaTBAQ&A
14:30-16:00
DIGITAL HEALTH AND CANNABIS – IS THE FUTURE HERE? BIG DATA, PREDICTION, AND ARTIFICIAL INTELLIGENCE
Cannformatics: A Bioinformatics and Big Data Approach to Personalized Medical Cannabis.
Itzhak Kurek, PhD, CEO & Co-Founder, Cannformatics Inc., Israel
Cannabis Big Data – Tracking Patient Outcomes for Predictive Analytics
David Berg, President and CTO, Strainprint Technologies Ltd, Canada
Jason Dyck, Canada Research Chair in Molecualr Medicine, University of Alberta, Board of Directors, Aurora Cannabis Inc, Canada
TBA
Q&A
14:30 – 16:00
DRUG DELIVERY
The Future Of Inhaled Cannabinoid-Based Medicine In Cancer: An Alternative Treatment To Improve Quality Of Life And Pain Management In Advanced Cancer Patients
Martin Chasen, Dr., Medical Director Palliative Care services, Tetra Bio-Pharma, Canada
Challenges in Medicalization of Cannabis
Hadile Ounallah-Saad, VP R&D, Cannassure, Israel
Transdermal delivery of cannabinoids: human case studies
Jeremy Riggle, Chief Scientist Mary’s Medicinals, USA
Q&A
.
PARALLEL SESSIONS
.
Innovations in Science and Medicine
09:00- 10:00
ORAL PRESENTATIONS
10:00- 11:30
PHYTO AND ENDOCANNABINOIDS – HOW TO COMBINE THE TWO FOR SYNERGETIC UNDERSTANDING
KEYNOTE LECTURE
Lumír Ondřej Hanuš, Prof. Chief Scientist, Lumir Labs, Israel
David (Dedi) Meiri, Prof. Head of Scientific Advisory Board, Technion, Institute of Technology, Israel
Role of Cannabidiolic Acid-Methy Ester (CBDA-ME) in a Preclinical Model of Peripheral Neuropathic Pain
Gurmit Singh, Prof. McMaster University, Hamilton, Canada
11:10- 11:30
THE NEXT STEP IN CANNABIS TREATMENT: THE BENEFITS OF CANNABIS MICRO DOSING
Turning the Clock: The Endocannabinoid System and Ageing.
Andreas Zimmer, Prof. Director, Institute of Molecular Psychiatry University of Bonn, Germany
New Technologies, New Opportunities
09:00- 10:00
ORAL PRESENTATIONS
10:00 – 11:30
ENTERING THE PHARMACEUTICAL INDUSTRY – HOW TO MEET PHARMA STANDARDS IN CANNABIS BASED PRODUCTS?
Chair: Dr Orna Dreazen, CEO and Chairperson on the Board of Directors, Nextar Chempharma Solutions, Israel
KEYNOTE LECTURE
TBA
Kevin Roland, Director, CMC (Chemical Manufacturing Controls), Canopy Health Innovation, Canopy Growth Corporation, Canada
Patrick Schmitt, CSO and Molecular Biologist, Farmako GmbH, Germany
Perry Davidson, Founder & CEO, Syqe Medical, Israel
How to Meet Pharma Standards in Cannabis Based Products
Orna Dreazen, Dr. CEO and Chairperson of the Board of Directors on Nextar Chempharma solutions Ltd., Israel
Trends in the Medicalization of Cannabis
Avihu Tamir, CEO, Kanabo Research, Israel
09:00- 10:00
ORAL PRESENTATIONS
10:00- 11:30
THC VS. CBD: THE IMPACT OF REGULATION ON RESEARCH – WILL THE HEMP INDUSTRY TAKEOVER?
Moderator: Heli Dangur, Director of Global Business Development, Cann10, Israel
Disease Specific CBD Use in Chronic Ailments
Miles Gilman, President Sunhealth Therapeutic, USA
Heli Dangur, Director of Global Business Development, Cann10, Israel
DEBATE: WILL THE HEMP INDUSTRY TAKEOVER?
Clifton Flack, Founder, Ciitech, Israel
Maayan Weisberg Joels, Business development Tikun Olam, Israel
PARALLEL SESSIONS
.
Innovations in Science and Medicine
12:00-13:00
TREATING AUTISM WITH MEDICAL CANNABIS
Randomized Study of Cannabinoid Treatment in Children with ASD
Adi Aran, Dr. Director of the Neuro-pediatric unit, Shaare Zedek Medical Center Jerusalem, Israel
PANEL DISCUSSION
Moderator: Adi Aran, Dr. Director of the Neuro-pediatric unit, Shaare Zedek Medical Center Jerusalem, Israel
Orit Stolar, Dr. Pediatric Neurologist, Assaf Harofeh Medical Center, Israel
Gal Meiri, Dr. Head of Preschool Psychiatric Unit Soroka Medical Center, Ben Gurion University of the Negev, Israel
Abigail Dar, Founder and CEO, CannaFora, Israel
Industry & Agriculture
12:00 – 13:00
HIGH-END TECHNOLOGIES FOR BEST CULTIVATION AND PLANT PROTECTION
Automated High Quality Controlled – The SAFE way to protect your harvest
Ofer Finkelstein, VP Sales, Juganu, Israel
TBA
PARALLEL SESSIONS
.
Innovations in Science and Medicine
14:00-15:30
FROM SMOKING TO NANO TECHNOLOGIES – NEW FINDINGS ON EFFECTIVE DRUG DELIVERY
Chair: Yossi Tam, Dr., Head, Obesity and Metabolism Laboratory, The Institute for Drug Research, Faculty of Medicine ,Director, Multidisciplinary Center on Cannabinoid Research, The Hebrew University of Jerusalem, Israel
Nano-Delivery Systems May Improve The Performance Of Cannabinoids
Simon Benita, Prof. Emeritus, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine The Hebrew University of Jerusalem, Israel
Improved Bioavailability of Cannabinoids
Abraham J Domb, PhD. Head of Biopolymers and Pharmaceutical Chemistry Lab, Leonel Jacobson, Israel
Novel Nanodomains as Vehicles for Enhanced Delivery for Cannabinoids
Nissim Garti, Prof.,Ph.D Ratner Chair of Chemistry Head of Casali Center of Applied Chemistry Nanoscience and Nanotechnology Center Head of Innovation Forum of Food Technology Institute of Chemistry The Hebrew University of Jerusalem, Israel
Q&A
New Technologies, New Opportunities
14:00 -15:30
GLOBAL TRADE: OVERCOMING IMPORT-EXPORT BARRIERS IN A CONSTANT CHANGING REGULATORY ENVIRONMENT
Moderator: Lior Kenan, Economics Correspondant, Chanel 13, Israel
PANEL DISCUSSION
Philippe Lucas,VP, Global Patient Research & Access, Tilray Social Dimensions of Health, University of Victoria Graduate Researcher, Canadian Institute for Substance Use Research, Canada
Hagit Weinstock, Owner and Partner Weinstock Zehavi & Co, Israel
Yossi Bornstein, Chairman, Cann10; CEO, Shizim – Biomed Holding Group, Israel
14:00 -14:45
DEBATE: AN EVIDENCE-BASED MEDICINE VS PRACTICE-DRIVEN DATA BASED CANNABINOID MEDICINE
Moderator: Yuval (Tuby) Zolotov, Dr.,Chief Operating Officer at Medical Cannabis Research Institute, Israel
Michael Dor, Dr The medical consultant of the medical cannabis unit at the Health Ministry, Israel
Victor Novack, Prof ., Head of Soroka Clinical Research Center, Israel
Johnny Grunfeld, Dr., Palliative Care, Asaf Harofeh Medical Center, Israel
Q&A
14:45 -15:05
TBA
15:05 -15:30
TBA
COFFEE BREAK & POSTER VIEWING & EXHIBITION VISIT
KEYNOTE LECTURE
TBA
PANEL DISCUSSION
Steve Hawkins,President & CEO at Horizons ETFs, Canada
Shiry Eden, Founder & CEO, Nishot, Israel
